Related Experiment Video
Updated: Jan 9, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
Published on: February 21, 2020
Developing a Statistical Modeling-Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump
Amanda Massmann1,2, Jordan F Baye1,2,3, Max Weaver1
1Sanford Health, Sioux Falls, South Dakota, USA.
Objective:
To develop a statistical model to capture medication dosing for proton pump inhibitors (PPIs) using structured data from electronic health records (EHR).
Methods:
Medication data for PPIs was extracted from a single health care system EHR to develop a statistical model. Nearly 20 years' worth of PPI prescriptions were extracted and 25% of unique dosing regimens were manually labeled by two clinical pharmacists. Several machine learning models were trained and evaluated to predict dose. Training was applied to 70% of the unique dosing regimens. The remaining unique dosing regimens were tested and validated with standard regression metrics: root mean squared error (RMSE) and R-squared.
Results:
A total of 17,271 distinct patients had orders for a PPI comprising 186,801 unique PPI orders. Distinct pairs built on medication descriptions and SIG combinations resulted in 10,739 unique entities. Clinical pharmacists manually labeled 2679 examples for medication entity extraction. Regression metrics (R-squared, RMSE) were chosen as metrics to evaluate model performance. A stacked ensembled model proved to have the best results with a 0.09 RMSE and an R-squared of 0.825.
Conclusion:
The development of a statistical model to capture PPI dosing for both maintenance and complex dosing strategies was highly sensitive and accurate. A supervised learning prediction model helps overcome challenges in medication dosing identification by addressing concerns related to variability and complexity. Future strategies should focus on integrating unstructured data within the algorithm to further refine medication dosing capture.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Dosage Regimens: Partial Pharmacokinetic Parameters
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...